Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risk factors for pancreatic adenocarcinoma and prospects for screening.

Literature DB >> 20567579

Risk factors for pancreatic adenocarcinoma and prospects for screening.

G Anton Decker, Mashal J Batheja, Joseph M Collins, Alvin C Silva, Kristin L Mekeel, Adyr A Moss, Cuong C Nguyen, Douglas F Lake, Laurence J Miller.

Abstract

Pancreatic cancer has one of the worst survival rates of any cancer and is the fourth leading cause of cancer mortality. Early detection and surgery are the patient's best chance for cure. However, symptoms are typically vague and occur when the cancer is unresectable. Population-based mass screening is not practical for this rare disease, though screening and early detection in asymptomatic high-risk patient populations may be indicated.

Entities: Disease Species

Keywords: Pancreatic cancer; inherited risk factors; noninherited risk factors; screening

Year: 2010 PMID： 20567579 PMCID： PMC2886484

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

101 in total

1. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis.

Authors: Shandra Bipat; Saffire S K S Phoa; Otto M van Delden; Patrick M M Bossuyt; Dirk J Gouma; Johan S Laméris; Jaap Stoker
Journal: J Comput Assist Tomogr Date: 2005 Jul-Aug Impact factor: 1.826

2. Pedigree of a family with hereditary chronic relapsing pancreatitis.

Authors: M W COMFORT; A G STEINBERG
Journal: Gastroenterology Date: 1952-05 Impact factor: 22.682

3. Familial pancreatic cancer (Part 1): Genetic pathology review.

Authors: H T Lynch; S J Lanspa; R J Fitzgibbons; T Smyrk; M L Fitzsimmons; J McClellan
Journal: Nebr Med J Date: 1989-05

4. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors: Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal: N Engl J Med Date: 2003-04-24 Impact factor: 91.245

5. Cancer Incidence in BRCA1 mutation carriers.

Authors: Deborah Thompson; Douglas F Easton
Journal: J Natl Cancer Inst Date: 2002-09-18 Impact factor: 13.506

6. Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study.

Authors: S T Chari; V Mohan; C S Pitchumoni; M Viswanathan; N Madanagopalan; A B Lowenfels
Journal: Pancreas Date: 1994-01 Impact factor: 3.327

7. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Authors: J W Poley; I Kluijt; D J Gouma; F Harinck; A Wagner; C Aalfs; C H J van Eijck; A Cats; E J Kuipers; Y Nio; P Fockens; M J Bruno
Journal: Am J Gastroenterol Date: 2009-06-02 Impact factor: 10.864

8. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population.

Authors: Jee-Eun Kim; Kyu Taek Lee; Jong Kyun Lee; Seung Woon Paik; Jong Chul Rhee; Kyoo Wan Choi
Journal: J Gastroenterol Hepatol Date: 2004-02 Impact factor: 4.029

9. Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images.

Authors: Yoshito Tsushima; Akie Takano; Ayako Taketomi-Takahashi; Keigo Endo
Journal: Acad Radiol Date: 2007-06 Impact factor: 3.173

10. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors: J Everhart; D Wright
Journal: JAMA Date: 1995 May 24-31 Impact factor: 56.272

12 in total

Review 1. Molecular biology of pancreatic cancer.

Authors: Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik
Journal: World J Gastroenterol Date: 2011-06-28 Impact factor: 5.742

2. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.

Authors: Umashankar K Ballehaninna; Ronald S Chamberlain
Journal: J Gastrointest Oncol Date: 2012-06

3. Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.

Authors: Umashankar K Ballehaninna; Ronald S Chamberlain
Journal: Indian J Surg Oncol Date: 2011-02-17

4. Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.

Authors: Daniel Ansari; Roland Andersson; Monika P Bauden; Bodil Andersson; Joanne B Connolly; Charlotte Welinder; Agata Sasor; György Marko-Varga
Journal: J Cancer Res Clin Oncol Date: 2014-09-13 Impact factor: 4.553

5. Diagnosis of pernicious anemia and the risk of pancreatic cancer.

Authors: Pari Shah; Andrew D Rhim; Kevin Haynes; Wei-Ting Hwang; Yu-Xiao Yang
Journal: Pancreas Date: 2014-04 Impact factor: 3.327

6. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.

Authors: Justin E Mirus; Yuzheng Zhang; Michael A Hollingsworth; Joell L Solan; Paul D Lampe; Sunil R Hingorani
Journal: Mol Cell Proteomics Date: 2014-09-15 Impact factor: 5.911

Review 7. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).

Authors: Joseph Carmicheal; Asish Patel; Vipin Dalal; Pranita Atri; Amaninder S Dhaliwal; Uwe A Wittel; Mokenge P Malafa; Geoffrey Talmon; Benjamin J Swanson; Shailender Singh; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal: Biochim Biophys Acta Rev Cancer Date: 2019-10-30 Impact factor: 10.680